Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CASI Pharmaceuticals, Inc. - Ordinary Shares (NQ:CASI)

0.8200 +0.0716 (+9.57%)
Streaming Delayed Price Updated: 11:02 AM EST, Feb 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about CASI Pharmaceuticals, Inc. - Ordinary Shares

< Previous 1 2 3 4 5 Next >
News headline image
HFCAA News: 128 Chinese Stocks the SEC Could Delist ↗
The SEC has released a massive list of Chinese stocks that could face delisting on Holding Foreign Companies Accountable Act news. 
Via InvestorPlace
News headline image
Recap: CASI Pharmaceuticals Q4 Earnings ↗
  CASI Pharmaceuticals (NASDAQ:CASI) reported its Q4 earnings results on Monday, March 28, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗
It's time for another breakdown of all the biggest pre-market stock movers as we go over the news for Wednesday morning. 
Via InvestorPlace
News headline image
27 Stocks Moving in Wednesday's Pre-Market Session ↗
Gainers Rail Vision Ltd. (NASDAQ: RVSN) shares rose 38.5% to $1.87 in pre-market trading after gaining around 5% on Tuesday. Brickell Biotech, Inc. (NASDAQ: BBI) rose 29% to $0.... 
Via Benzinga
News headline image
Most Chinese Biotech Stocks Can Continue US Listing After New Audit Framework ↗
 
Via Benzinga
News headline image
Baidu, iQIYI Explore Options After US SEC Added Them To Provisional List Pending Audit Review ↗
 
Via Benzinga
News headline image
CASI Pharmaceuticals's Return On Capital Employed Insights ↗
According to data from Benzinga Pro, during Q4, CASI Pharmaceuticals's (NASDAQ:CASI) reported sales totaled $9.16 million. Despite a 46.15% increase in earnings, the company posted a loss of $5.39... 
Via Benzinga
News headline image
Earnings Scheduled For March 28, 2022 ↗
Companies Reporting Before The Bell • LGL Group (AMEX:LGL) is likely to report quarterly earnings at $0.10 per share on revenue of $7.20 million. 
Via Benzinga
News headline image
Earnings Outlook For CASI Pharmaceuticals ↗
CASI Pharmaceuticals (NASDAQ:CASI) is set to give its latest quarterly earnings report on Monday, 2022-03-28. Here's what investors need to know before the announcement. Analysts... 
Via Benzinga
News headline image
How To Attend CASI Pharmaceuticals Q4 2021 Earnings Conference Call ↗
CASI Pharmaceuticals (NASDAQ:CASI) will host a conference call at 08:00 AM ET on March 28, 2022, to discuss Q4 2021 earnings results. How to Attend CASI Pharmaceuticals (... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
Gainers Calyxt (NASDAQ:CLXT) shares rose 12.4% to $1.63 during Friday's pre-market session. The company's market cap stands at $62.7 million. Better Therapeutics (... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
Gainers Anixa Biosciences (NASDAQ:ANIX) s... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
Gainers Idera Pharmaceuticals (NASDAQ:IDRA) stock rose 13.0% to $0.71 during Friday's pre-market session. The market value of their outstanding shares is at $37.7... 
Via Benzinga
News headline image
Casi Pharma-Partnered BioInvent's Lead Cancer Program Gets FDA Orphan Drug Tag ↗
The FDA has granted Orphan Drug Designation to BioInvent International AB's (OTC: BOVNF) BI-1206, an anti-FcyRllB antibody, for follicular lymphoma (FL)... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Genfit Spikes On Liver Disease Drug Licensing Deal, Lyell Gets Nod For Solid Tumor Study, Decision-Day For Intra-Cellular, Argenx ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Merck Announces Publication Of Positive Data From Late-Stage Study Of Oral... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
Gainers Adicet Bio (NASDAQ:ACET) stock increased by 37.85% to $13.51 during Monday's pre-market session. The market value of their outstanding shares is at $431.7... 
Via Benzinga
News headline image
40 Stocks Moving In Monday's Mid-Day Session ↗
Gainers iSpecimen Inc. (NASDAQ: ISPC) shares climbed 126.5% to $11.12 after the company announced it has been contracted to support new advanced research on COVID-19 seeking... 
Via Benzinga
News headline image
The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More ↗
The omicron variant concerns were front and center in the markets in the week ended Dec. 3, and biotech stocks did not escape the brunt of selling in the wake of the negative... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
Gainers iSpecimen (NASDAQ:ISPC) stock rose 31.09% to $6.45 during Monday's pre-market session. The company's market cap stands at $44.9 million. Provention Bio (... 
Via Benzinga
News headline image
5 Penny Stocks Insiders Are Buying ↗
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider... 
Via Benzinga
News headline image
20 Stocks Moving in Monday's Pre-Market Session ↗
Gainers Astra Space, Inc. (NASDAQ: ASTR) rose 39.6% to $13.30 in pre-market trading after declining around 3% on Friday. Astra Space recently reported a Q3 loss of $0.06 per... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
Gainers CASI Pharmaceuticals (NASDAQ:CASI 
Via Benzinga
News headline image
The Daily Biotech Pulse: J&J To Spin-off Consumer Health Business, AstraZeneca Earnings, Embattled Emergent To Buy Back Shares ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus J&J to Separate Its Consumer Health Business Into a New Publicly Traded... 
Via Benzinga
News headline image
Earnings Scheduled For November 12, 2021 ↗
Companies Reporting Before The Bell • Zevia (NYSE:ZVIA) is estimated to report quarterly loss at $0.43 per share on revenue of $34.40 million. • Natura &Co... 
Via Benzinga
News headline image
CASI Pharmaceuticals Earnings Preview ↗
CASI Pharmaceuticals (NASDAQ:CASI) is set to give its latest quarterly earnings report on Friday, 2021-11-12. Here's what investors need to know before the announcement. Analysts... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
Gainers Triple-S Management (NYSE:GTS) stock moved upwards by 44.27% to $34.9 during Tuesday's pre-market session. The market value of their outstanding shares is at $... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6) Enanta Pharmaceuticals, Inc... 
Via Benzinga
News headline image
60 Biggest Movers From Yesterday ↗
Gainers Trillium Therapeutics Inc. (NASDAQ: TRIL) shares jumped 188.8% to close at $17.59 on Monday after the company agreed to be acquired by Pfizer for $18.50 per share,... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
Gainers Vivos Therapeutics (NASDAQ:VVOS) stock rose 45.44% to $5.58 during Monday's regular session. As of 12:30 EST, Vivos Therapeutics's stock is trading at a... 
Via Benzinga
News headline image
35 Stocks Moving In Monday's Mid-Day Session ↗
Gainers Trillium Therapeutics Inc. (NASDAQ: TRIL) shares climbed 187.8% to $17.53 after the company agreed to be acquired by Pfizer for $18.50 per share, implying an equity value... 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.